Unimed Pharmaceuticals In July 1999, Solvay Pharmaceuticals, Inc. acquired Unimed Pharmaceuticals, Inc.  The company is now a wholly-owned subsidiary of Solvay Pharmaceuticals.  Unimed focuses on developing and marketing drugs with multiple indications in the specialized markets of men's health (urology and endocrinology), HIV and other infectious diseases. Organics L.L.C. For over 60 years, Organics has synthesized and isolated active pharmaceutical ingredients (APIs), with a current focus on the complex, multi-component synthetic conjugated and esterified estrogens.  Serving as an extension of its customers’ in-house laboratories, Organics offers an exceptional depth of knowledge, an extensive collection of advanced equipment and the FDA compliance expertise needed to help move projects forward in the highly competitive, highly regulated pharmaceutical environment.  Organics L.L.C. is a wholly-owned subsidiary of Solvay Pharmaceuticals, Inc. Solvay Biologicals, LLC  Solvay Biologicals, LLC is a wholly-owned subsidiary of Solvay Pharma US Holdings, Inc., the same parent company of Solvay Pharmaceuticals, Inc. Launched in January 2008, the company focuses exclusively on the research and development and ultimately, the manufacturing of the company’s cell-based influenza vaccine in the U.S.